TATA HEALTH (01255): Wang Jian Resigns as Independent Non-Executive Director

Stock News
Sep 03

TATA HEALTH (01255) announced that effective September 3, 2025: Mr. Wang Jian has submitted his resignation as independent non-executive director due to his decision to devote more time to other work commitments, and will no longer serve as chairman of the company's audit committee, remuneration committee, and nomination committee respectively. Independent non-executive director Ms. Huang Lin has been appointed to replace Mr. Wang Jian as chairman of the audit committee, remuneration committee, and nomination committee. Mr. Lin Zheming has submitted his resignation as non-executive director due to his decision to devote more time to other work commitments. Mr. Lai Wenjing has submitted his resignation as Chief Financial Officer of the company due to his decision to devote more time to other work commitments.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10